Get Real Time Here
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
SCYNEXIS Stock (NASDAQ:SCYX), Quotes and News Summary
SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
| Open2.350 | Close2.280 |
| Vol / Avg.354.925K / 399.959K | Mkt Cap87.363M |
| Day Range2.250 - 2.470 | 52 Wk Range1.150 - 3.870 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 1.550 | 2.460 | 0.9100 | ||||
| REV | 95.450M | 131.454M | 36.004M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Cantor Fitzgerald | Louise Chen | Reiterates | OverweightOverweight | Maintains | - | 15.00 |
| 2023-04-03 | Guggenheim | Vamil Divan | Maintains | Buy | Raises | 8.00 | 9.00 |
| 2023-04-03 | Ladenburg Thalmann | Michael Higgins | Reiterates | Buy | Maintains | - | 15.00 |
| 2023-03-01 | Guggenheim | Vamil Divan | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| SCYX | SCYNEXIS | 2.17% | 87.4M |
| OCUP | Ocuphire Pharma | -1.15% | 73M |
| RANI | Rani Therapeutics Hldgs | -17.74% | 55.7M |
| AQST | Aquestive Therapeutics | -0.67% | 99.4M |
| ESPR | Esperion Therapeutics | 3.34% | 105.9M |
How do I buy SCYNEXIS (SCYX) stock?
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Who are SCYNEXIS's (SCYX) competitors?
Other companies in SCYNEXIS’s space includes: Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI), Aquestive Therapeutics (NASDAQ:AQST), Esperion Therapeutics (NASDAQ:ESPR) and Incannex Healthcare (NASDAQ:IXHL).
What is the target price for SCYNEXIS (SCYX) stock?
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Tuesday, August 15, 2023. The analyst firm set a price target for 15.00 expecting SCYX to rise to within 12 months (a possible 538.30% upside). 5 analyst firms have reported ratings in the last year.
Current Stock Price for SCYNEXIS (SCYX)?
The stock price for SCYNEXIS (NASDAQ: SCYX) is $2.35 last updated September 29, 2023 at 9:04 PM UTC.
Does SCYNEXIS (SCYX) pay a dividend?
There is no dividend information for SCYNEXIS.
When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?
SCYNEXIS’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
Is SCYNEXIS (SCYX) going to split?
There is no upcoming split for SCYNEXIS.
What sector and industry does SCYNEXIS (SCYX) operate in?
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.